CA Patent

CA2680249A1 — Imatinib mesylate

Assigned to Dr Reddys Laboratories Ltd · Expires 2008-09-18 · 18y expired

What this patent protects

There is provided a solid dispersion of imatinib mesylate that includes imatinib mesylate and a pharmaceutically acceptable carrier, wherein said carrier is a cellulose derivative. Also provided is a process for making a solid dispersion and a process for making imatinib.

USPTO Abstract

There is provided a solid dispersion of imatinib mesylate that includes imatinib mesylate and a pharmaceutically acceptable carrier, wherein said carrier is a cellulose derivative. Also provided is a process for making a solid dispersion and a process for making imatinib.

Drugs covered by this patent

Patent Metadata

Patent number
CA2680249A1
Jurisdiction
CA
Classification
—
Expires
2008-09-18
Drug substance claim
No
Drug product claim
No
Assignee
Dr Reddys Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.